We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Taste of their own medicine

17 November 2004 By Robert Cyran

Expected job cuts and factory closures at the world’s second largest generics producer highlight shrinking margins throughout the industry. Competition has become bloodier since the introduction of "authorised generics", which savage the most lucrative part of the industry.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)